Abstract
A single-center, randomized, double-blind, controlled clinical trial with four arms was conducted in healthy subjects with persistent knee discomfort (pain intensity on 1-10 cm visual analog scale (VAS) > 3) aged 40 years and older treated with a dietary supplement for 8 weeks. The study groups were Boswellia serrata extract (n = 29), an omega-3-based product (AvailOm(®) 50 High EPA) (n = 31), Boswellia + AvailOm(®) (n = 30), and placebo (n = 30). The intake of Boswellia + AvailOm(®) improved the quality of life (QoL) (WOMAC index) and some variables of muscle strength. Statistically significant differences between the AvailOm(®) and the placebo groups in the decrease of pain intensity were found. Weekly VAS scores showed a significant decrease in pain perception when comparing the AvailOm(®) product to the placebo, with the lowest VAS scores at week 8. Consumption of Boswellia improved sleep latency. The time to perform the Up and Go test decreased after the intake of AvailOm(®). There was an increase in the omega-3 fatty acids, with the greatest increase in the Boswellia + AvailOm(®) group. AvailOm(®) was safe and effective in reducing pain and improving the QoL and functionality of subjects over 40 years with persistent knee pain.